Abstract
Understanding the causes of axonal pathology remains a key goal in the pursuit of new therapies to target disease progression in MS. Anterograde axonal transport of many proteins vital for axonal viability is mediated by the motor protein KIF5A, which has been linked to several neurological diseases. This study aimed to investigate the expression of KIF5A protein and its associated cargoes: amyloid precursor protein (APP) and neurofilament (NF) in post-mortem MS and control white matter and to determine if KIF5A expression is influenced by the presence of MS risk single nucleotide polymorphisms (SNPs) identified in the region of the KIF5A gene.
MethodsUsing immunoblotting assays we analyzed the expression of KIF5A, APP and NF phospho-isoforms in 23 MS cases and 12 controls.
ResultsWe found a significant reduction in KIF5A and associated cargoes in MS white matter and an inverse correlation between KIF5A and APP/NF protein levels. Furthermore, homozygous carriers of MS risk gene SNPs show significantly lower levels of KIF5A protein compared to MS patients with no copies of the risk SNPs.
ConclusionsWe conclude that reduced expression of axonal motor KIF5A may have important implications in determining axonal transport deficits and ongoing neurodegeneration in MS.
Original language | English |
---|---|
Pages (from-to) | 227–241 |
Number of pages | 15 |
Journal | Neuropathology and Applied Neurobiology |
Volume | 43 |
Issue number | 3 |
Early online date | 1 Apr 2016 |
DOIs | |
Publication status | Published - Apr 2017 |
Keywords
- amyloid precursor protein
- axonal transport
- KIF5A
- multiple sclerosis
- neurofilament
- single nucleotide polymorphism
- white matter
Fingerprint
Dive into the research topics of 'Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter'. Together they form a unique fingerprint.Profiles
-
Dr Claire M Rice
- Bristol Medical School (THS) - Associate Professor in Neuroinflammation
- Multiple Sclerosis and Stem Cell Group
- Bristol Neuroscience
Person: Academic , Member, Group lead